In a significant boost for India’s burgeoning direct-to-consumer (D2C) intimate wellness sector, HealthFab, a startup dedicated to innovative period care and intimate hygiene solutions, has successfully closed a Pre-Series A funding round of Rs 65 crore. This capital infusion arrives at a pivotal moment, as Indian consumers, particularly women, are increasingly prioritizing personal well-being and seeking high-quality, specialized products. HealthFab’s strategic raise underscores a growing investor confidence in brands that address specific, often overlooked, consumer needs with a blend of innovation, sustainability, and educational outreach. This funding will be instrumental in scaling their mission to destigmatize and simplify intimate health for millions of women across the country.
About HealthFab: Pioneering a New Era in Women’s Wellness
Founded in 2021 by Sourav Roy, HealthFab embarked on a mission to redefine women’s intimate wellness, starting with a focus on period care. The company’s flagship product, Sanfe, has quickly gained traction for its innovative range of period products, including reusable sanitary pads, period pain relief solutions, and intimate hygiene products. HealthFab operates with a strong commitment to quality, comfort, and sustainability, positioning itself as a trusted brand in a market often dominated by traditional, less eco-friendly alternatives.
Sourav Roy’s vision for HealthFab stemmed from a deep understanding of the challenges women face regarding menstrual hygiene and intimate health in India. The brand aims to empower women by providing accessible, effective, and discreet solutions, coupled with a strong emphasis on education and breaking societal taboos. Since its inception, HealthFab has seen impressive growth, driven by a direct-to-consumer model that allows for direct engagement with its customer base and agile product development based on feedback. While specific revenue figures were not disclosed, the rapid expansion of its product lines and increasing market penetration signal a strong growth trajectory.
The Deal: A Strategic Capital Infusion to Fuel Expansion
HealthFab has successfully raised Rs 65 crore in a Pre-Series A funding round. The round saw participation from a consortium of prominent investors, reflecting strong belief in HealthFab’s market potential and operational strategy. The lead investor for this round was Poonawalla Fincorp, a notable financial services company. Co-investors included XLRC, Mumbai Angels, Shantanu and Nikhil (the renowned fashion designers), and Aditya and Krishna Kumar (founders of Purplle). The valuation for this round was not publicly disclosed.
Poonawalla Fincorp’s decision to lead this round is particularly noteworthy. While primarily known for its lending operations, its strategic investment in HealthFab signals a broader interest in high-growth consumer brands that align with evolving societal needs. Their involvement provides not just capital, but also potential strategic insights into financial management and market scaling. The participation of Mumbai Angels, a well-established angel network, indicates continued confidence from the early-stage investment community, validating HealthFab’s foundational strength and innovative approach.
The involvement of Shantanu and Nikhil, prominent figures in the fashion industry, brings an interesting dimension to the investment. Their discerning eye for consumer trends and brand aesthetics could prove valuable for HealthFab’s marketing and brand positioning efforts, particularly as intimate wellness becomes increasingly intertwined with lifestyle and self-care. Similarly, Aditya and Krishna Kumar, with their success in building Purplle, a leading beauty and personal care e-commerce platform, bring invaluable operational and market expertise in the D2C space. Their investment is a strong endorsement from founders who have navigated similar challenges and achieved significant scale.
Use of Funds: Strategic Deployment for Growth and Innovation
The newly secured capital of Rs 65 crore will be strategically deployed across several key areas to accelerate HealthFab’s growth and solidify its market position. A significant portion of the funds will be allocated towards product development and innovation. This includes research and development for new offerings in the period care and intimate hygiene segments, potentially expanding into related women’s health categories. The company aims to continue its trajectory of introducing science-backed, user-centric products that address unmet needs.
Another crucial area for investment is geographic expansion. HealthFab plans to broaden its reach across India, targeting both metropolitan and tier-2 and tier-3 cities, where awareness and access to specialized intimate wellness products are growing. This will involve strengthening its distribution network and enhancing its online presence to cater to a wider audience.
Furthermore, the funds will be utilized for marketing and brand building initiatives. HealthFab intends to amplify its educational campaigns, aiming to destigmatize conversations around menstrual health and intimate hygiene. This will involve digital marketing, influencer collaborations, and community engagement programs to foster a supportive environment for women to discuss and address their wellness needs openly. Team expansion will also be a priority, with investments in attracting top talent across R&D, marketing, sales, and operations to support the company’s ambitious growth plans.
Market Opportunity: Tapping into a Growing Conscious Consumer Base
The Indian intimate wellness market, particularly within the women’s health segment, presents a colossal and largely untapped opportunity. Historically, this sector has been characterized by limited innovation, a lack of specialized products, and pervasive societal taboos that hinder open discussion and access. However, a significant shift is underway. Increased awareness, rising disposable incomes, and the widespread adoption of e-commerce are catalyzing demand for high-quality, sustainable, and effective solutions.
The market for feminine hygiene products alone in India is projected to grow substantially, driven by a younger, more informed demographic that prioritizes health and wellness. HealthFab is strategically positioned to capture a significant share of this growth by offering products that go beyond basic functionality, incorporating aspects of comfort, sustainability, and advanced formulations. The competitive landscape includes both established players offering conventional products and a growing number of D2C startups specializing in niche wellness categories. HealthFab differentiates itself through its strong focus on R&D, commitment to sustainable practices (e.g., reusable pads), and a holistic approach to intimate wellness that includes educational content and community building.
The direct-to-consumer model allows HealthFab to gather immediate feedback, iterate quickly on products, and build a strong, loyal customer base. This agility is a distinct advantage over larger, more traditional FMCG companies that often struggle to adapt to rapidly changing consumer preferences. The increasing willingness of Indian consumers to pay a premium for specialized health and personal care products further validates HealthFab’s premium positioning and growth potential.
What’s Next: Expanding Reach and Deepening Impact
With this fresh injection of capital, HealthFab is poised for an accelerated growth phase. The company’s immediate milestones include a significant expansion of its product portfolio, with plans to introduce new solutions that address a broader spectrum of women’s intimate health concerns. This could involve exploring areas like postpartum care, menopausal support, or specialized dermatological solutions for intimate areas, further solidifying its position as a comprehensive wellness brand.
Geographically, HealthFab aims to penetrate deeper into India’s diverse consumer base, leveraging both its online channels and strategic offline partnerships. The focus will be on building robust supply chains and localized marketing strategies to cater to regional nuances. The company is also expected to significantly ramp up its marketing efforts, not just for product promotion, but also to continue its crucial work in destigmatizing conversations around women’s intimate health. This educational outreach is integral to its brand identity and long-term vision.
While no specific timeline for the next funding round was disclosed, the successful Pre-Series A round sets a strong foundation for a larger Series A in the coming 12-18 months, as HealthFab demonstrates significant traction and achieves its expansion targets. The company’s trajectory suggests it is well on its way to becoming a leading voice and provider in India’s evolving women’s intimate wellness market, empowering women with better choices and greater confidence.
